Oculis Announces First Patient First Visit in Phase 3 OPTIMI

Oculis Announces First Patient First Visit in Phase 3 OPTIMIZE-2 Trial of OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery

Oculis Announces First Patient First Visit in Phase 3 OPTIMIZE-2 Trial of OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Switzerland , Boston , Massachusetts , United States , Eric Donnenfeld , Sylvia Cheung , Lifesci Advisorscorey Davis , Oculis Holding , Oculis Holding Ag Nasdaq , Exchange Commission , Nasdaq , Drug Administration , Diabetic Macular Edema , Cystoid Macular Edema , First Patient Visit , Once Daily Post Ocular , Chief Executive Officer , Acute Optic Neuritis , Clinical Professor , New York University , Oculis Scientific Advisory Board , Leveraging Oculi , Rochester Epidemiology Project , Ophthalmic Surgical Products Market , Sci Advisorscorey Davis , Risk Factors ,